retatrutide trial results today New Phase 3 retatrutide data just dropped 👀 Eli Lilly's trial reported Retatrutide shows significant weight loss

Description

doi: 10.1001/jamainternmed.2013.2720 221 KnapenLMvan DalemJKeulemansYCvan ErpNPBazelierMTDe BruinMLet al

Even though we realistically know that perfection isnt reasonable or necessary, we can still beat ourselves up over eating carbohydrates or dessert

Main text Modern GLP-1 receptor agonists and co-agonists (GLP-1 medicines) such as liraglutide, dulaglutide semaglutide, and the GLP-1R/glucose dependent insulinotropic polypeptide receptor (GIPR) co-agonist tirzepatide, were initially developed for the treatment of type 2 diabetes (T2D) due to their actions to increase insulin and decrease glucagon secretion and slow gastric emptying through effects on the pancreas and brain